Advanced Enzyme Approves ₹69.7 Cr Share Buyback

Advanced Enzyme Technologies Ltd announced its Board of Directors has approved a share buyback program. The company will repurchase fully paid-up equity shares via the open market mechanism through stock exchanges. The buyback is priced at a maximum of ₹500 per share, with an aggregate amount not exceeding ₹697,000,000 (₹69.7 crore). This buyback, representing up to 1.24% of the company's equity capital, excludes shares held by promoters and persons in control. The board also approved the un-audited financial results for Q1 FY27 and the acquisition of the remaining 4.28% stake in JC Biotech Private Limited, which will make it a wholly-owned subsidiary. Additionally, an investment of up to ₹20 million in Advanced Nutrazyme Private Limited was approved.